Actively Recruiting
Profiles of Urinary Tract Infections in General Practice
Led by CNGE Conseil · Updated on 2024-07-03
500
Participants Needed
1
Research Sites
59 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Urinary tract infections (UTIs) are one of the most common bacterial infections managed in general practice: they are the 2nd site of community-acquired bacterial infection after respiratory infections (4-6 million consultations per year in France). UTIs represent 15% of total antibiotic prescriptions in France. Antibiotics recommended for UTIs, except for cystitis, are considered as "critical" (highly generating bacterial resistances). UTIs are a potential source of antibiotic resistance: often inappropriate antibiotic prescriptions, evolution of the resistance profiles of the bacteria involved, emergence of multi-resistant strains. The first hypothesis is that there are other profiles of clinical UTI situations in general practice than typical cystitis or pyelonephritis, including intermediate forms. The second hypothesis is that these intermediate forms of UTI are subject to longer durations of antibiotherapy, and that probable explanatory factors need to be identified.
CONDITIONS
Official Title
Profiles of Urinary Tract Infections in General Practice
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient 18 years old or older
- Patient presenting one or more clinical signs suggestive of urinary tract infection during general practice consultation, including fever over 38°C, chills or sweats, burning urination, urinary urgency, frequent urination, pain when urinating, lumbar or pelvic pain, abnormal urine appearance (cloudy, smelly, or visible blood), absence of vaginal discharge
- For patients over 70 years old, additional signs include recent urinary incontinence, sudden confusion, or bladder distension
- Positive urine dipstick test and/or positive cytobacteriological urine examination
- Patient affiliated with the French National Health Insurance or beneficiary of such a scheme
- Patient provides oral non-opposition to participate after full information about the study
You will not qualify if you...
- Patient under 18 years old
- Pregnant patient
- Patient with an indwelling urinary catheter
- Patient with functional or structural abnormalities of the urinary tract
- Patient with known severe immunodeficiency (such as HIV with CD4 count under 200/mm3, organ or bone marrow transplant, on immunosuppressants, or cirrhosis)
- Patient with severe chronic kidney failure (clearance under 30 mL/min)
- Patient treated with antibiotics in the past month for reasons other than current UTI or treatment failure of UTI
- Patient with limited French language skills
- Patient with severe cognitive impairment
- Patient with life expectancy under 3 months
- Patient under legal protection or unable to provide oral non-opposition
- Patient with severity criteria requiring hospitalization
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cabinet de groupe
Saint-Maur-des-Fossés, Saint Maur, France, 94100
Actively Recruiting
Research Team
V
Véronique ORCEL, Dr
CONTACT
E
Emilie FERRAT, Dr
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here